Literature DB >> 26974273

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study.

F V Michelis1, E G Atenafu2, S Couban3, J Frazer3, S Shivakumar3, D E Hogge4, C L Toze4, W Rajkhan4, H J Kim5, A Daly6, J Slaby6, J Finke7, T Kiss8, C Bredeson9, M Sabloff9, D Sheppard9, M Bakkar9, M Brune10, D A Wall11, K Paulson11, G Popradi12, I Walker13, H A Messner1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26974273     DOI： 10.1038/bmt.2016.60

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission.

Authors:  Alan K Burnett; Anthony Goldstone; Robert K Hills; Donald Milligan; Archie Prentice; John Yin; Keith Wheatley; Ann Hunter; Nigel Russell
Journal:  J Clin Oncol       Date:  2013-02-25       Impact factor: 44.544

2.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

3.  Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.

Authors:  Martin S Tallman; Gordon W Dewald; Sharavi Gandham; Brent R Logan; Armand Keating; Hillard M Lazarus; Mark R Litzow; Jayesh Mehta; Tanya Pedersen; Waleska S Pérez; Jacob M Rowe; Meir Wetzler; Daniel J Weisdorf
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

4.  Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM).

Authors:  M Michallet; X Thomas; J P Vernant; M Kuentz; G Socié; H Espérou-Bourdeau; N Milpied; D Blaise; B Rio; J Reiffers; J P Jouet; J Y Cahn; J H Bourhis; B Lioure; M Leporrier; J J Sotto; G Souillet; L Sutton; P Bordigoni; F Dreyfus; H Tilly; N Gratecos; M Attal; P Y Leprise; F Déméocq; G Michel; A Buzyn; B Delmas-Marsalet; F Bernaudin; N Ifrah; A Sadoun; D Guyotat; M Cavazzana-Cavo; D Caillot; T De Revel; J P Vannier; A Baruchel; N Fegueux; M L Tanguy; A Thiébaut; A Belhabri; E Archimbaud
Journal:  Bone Marrow Transplant       Date:  2000-12       Impact factor: 5.483

5.  Prognostic index for adult patients with acute myeloid leukemia in first relapse.

Authors:  Dimitri A Breems; Wim L J Van Putten; Peter C Huijgens; Gert J Ossenkoppele; Gregor E G Verhoef; Leo F Verdonck; Edo Vellenga; Georgine E De Greef; Emanuel Jacky; Johannes Van der Lelie; Marc A Boogaerts; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2005-01-04       Impact factor: 44.544

6.  Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.

Authors:  Saiko Kurosawa; Takuhiro Yamaguchi; Shuichi Miyawaki; Naoyuki Uchida; Toru Sakura; Heiwa Kanamori; Kensuke Usuki; Takuya Yamashita; Yasushi Okoshi; Hirohiko Shibayama; Hirohisa Nakamae; Momoko Mawatari; Kazuo Hatanaka; Kazutaka Sunami; Manabu Shimoyama; Naohito Fujishima; Yoshinobu Maeda; Ikuo Miura; Yoichi Takaue; Takahiro Fukuda
Journal:  Haematologica       Date:  2010-07-15       Impact factor: 9.941

7.  Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR.

Authors:  F V Michelis; E G Atenafu; V Gupta; D D Kim; J Kuruvilla; A Lambie; J H Lipton; D Loach; H A Messner
Journal:  Bone Marrow Transplant       Date:  2013-05-20       Impact factor: 5.483

8.  Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.

Authors:  Paul M Armistead; Marcos de Lima; Sherry Pierce; Wei Qiao; Xuemei Wang; Peter F Thall; Sergio Giralt; Farhad Ravandi; Hagop Kantarjian; Richard Champlin; Elihu Estey
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-01       Impact factor: 5.742

9.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  D Grimwade; H Walker; F Oliver; K Wheatley; C Harrison; G Harrison; J Rees; I Hann; R Stevens; A Burnett; A Goldstone
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113
  9 in total
  1 in total

1.  Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia.

Authors:  J Frazer; S Couban; S Doucette; S Shivakumar
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.